Business
Sphero lays off more than 40 employees
The decision of Sphero to perform job cuts surprised its employees, especially those who saw the company’s growth.
Sphero, a tech toy company, has laid off dozens of staff members globally, according to a TechCrunch report.
The layoffs affected several departments in the company, and the majority of those who lost their jobs were from the Colorado headquarters, while the others were those who worked at the U.K. and Hong Kong offices, the site said.
Bit of a surprise
The staff cuts come as a “bit of a surprise” to many who have watched the company grow and enter into a deal with Disney just last year, TechCrunch reported.
After taking part in Disney’s accelerator in 2014, Sphero received a small investment from Disney and began production on a BB-8 toy that was made and released alongside “Star Wars: The Force Awakens” in 2015.
Following his departure at Sphero, co-founder and former CTO Ian Bernstein had just created a spin-off company named Misty Robotics that launched a robot for programmers, and previous Sphero employees also joined Bernstein at Misty.
TechCrunch described Sphero as a company that was ready to conquer on the tech toy world last year.
Sphero also “quintupled its product release schedule, flying high with the help of a Disney licensing deal that gave the world several Star Wars droids and talking Spider-Man and Lightning McQueen robots.”
Expectations were not met
But a company spokesperson told TechCrunch that the holiday season did not live up to expectations.
A spokesperson for Sphero told TechCrunch, “We restructured our team on Friday to better align with our product needs.”
“As we look to our product development schedule for 2018 and beyond, we weren’t going to go that deep, so we had to make some changes for how the teams were structured.”
The move is a step back for the company and a bit of a surprise for those who have been following its trajectory from afar.
—
DISCLAIMER: This article expresses my own ideas and opinions. Any information I have shared are from sources that I believe to be reliable and accurate. I did not receive any financial compensation in writing this post, nor do I own any shares in any company I’ve mentioned. I encourage any reader to do their own diligent research first before making any investment decisions.
(Featured image by StickerGiant Custom Stickers via Flickr. CC BY 2.0)
-
Africa2 weeks ago
Souss-Massa Launches ‘Back to Business’: Accelerating Investment with Bold Strategies
-
Biotech7 days ago
Vytrus Biotech Reports Its Best Quarter: Record Revenue and Rising EBITDA
-
Cannabis2 weeks ago
Ireland: Legislative Committee Calls for Legalization of Cannabis and Decriminalization of Drugs
-
Biotech4 days ago
Dijon Biotech Company Inventiva Raises 348 Million to Complete Its Phase III
You must be logged in to post a comment Login